Press Releases and Statements
Official announcements and statements from Americans for Safe and Effective Medicines.
-
FDA’s Updated Guidance on Compounded GLP-1 Products is Welcome, but Illegal Actions Merit Enforcement Actions
Americans for Safe and Effective Medicines Chief Policy Officer Fred Mills, PharmD, responds to FDA’s updated guidance on unapproved GLP-1 drugs used for weight loss and calls for enforcement against illegal marketing and distribution.
-
ASEM Statement: Protecting Young People from Illegal Retatrutide, Other Drugs on Social Media
Meta has announced new protections for young users on Facebook and Instagram. ASEM urges social media platforms to extend those safeguards to illegal and unapproved medicines marketed to young people online.
-
ASEM Applauds Medical Board of California
Americans for Safe and Effective Medicines (ASEM) commends the Medical Board of California for taking action against a San Diego medical office accused of compounding and administering injectable semaglutide and tirzepatide in unsafe conditions. According to the Board, the facility lacked basic safeguards necessary for sterile drug production, including a certified cleanroom, appropriate air filtration,…
-
A Statement on Needed Reforms to Protect Patient Safety from Fred H. Mills Jr., PharmD – ASEM Chief Policy Officer
“As a compounding pharmacist for nearly 50 years, I know the importance of legitimate, patient-specific compounding. I also know that there is a fundamental difference between the compounding that ensures a cancer patient has the right treatment dosage versus the mass compounding of GLP-1s today – unvetted additives, no batch consistency, telehealth distribution by faux-pharmacists,…
-
Americans for Safe and Effective Medicines Launches
Americans for Safe and Effective Medicines (ASEM) today launched as a new national advocacy organization dedicated to protecting patients from illegal mass compounding, counterfeit products, and misleading marketing practices and holding bad actors accountable…